Jpmorgan Chase & CO Vera Therapeutics, Inc. Transaction History

Jpmorgan Chase & CO

$1.23 Trillion
Q4 2024

A detailed history of Jpmorgan Chase & CO transactions in Vera Therapeutics, Inc. stock. As of the latest transaction made, Jpmorgan Chase & CO holds 221,485 shares of VERA stock, worth $6.33 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

221,485

Previous 129,095 71.57%

Holding current value

$6.33 Million

Previous $5.7 Million 64.2%

% of portfolio

0.0%

Previous 0.0%

19 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Feb 12, 2025	BUY	$38.64 - $49.75 $3.57 Million - $4.6 Million	92,390 Added 71.57%	221,485 $9.37 Million
Q3 2024 Dec 26, 2024	SELL	$34.09 - $46.71 $159,507 - $218,556	-4,679 Reduced 3.5%	129,095 $5.7 Million
Q3 2024 Nov 08, 2024	SELL	$34.09 - $46.71 $1.81 Million - $2.47 Million	-52,979 Reduced 39.6%	80,795 $3.57 Million
Q2 2024 Dec 26, 2024	BUY	$33.72 - $48.82 $1.79 Million - $2.59 Million	52,979 Added 65.57%	133,774 $4.84 Million
Q2 2024 Aug 12, 2024	SELL	$33.72 - $48.82 $6.8 Million - $9.85 Million	-201,790 Reduced 60.13%	133,774 $4.84 Million
Q1 2024 Dec 26, 2024	BUY	$14.91 - $49.14 $3.8 Million - $12.5 Million	254,769 Added 315.33%	335,564 $14.5 Million
Q1 2024 May 10, 2024	BUY	$14.91 - $49.14 $4.54 Million - $14.9 Million	304,219 Added 970.55%	335,564 $14.5 Million
Q4 2023 Dec 26, 2024	SELL	$9.29 - $16.0 $459,390 - $791,200	-49,450 Reduced 61.2%	31,345 $482,000
Q4 2023 Feb 12, 2024	BUY	$9.29 - $16.0 $76,958 - $132,544	8,284 Added 35.92%	31,345 $482,000
Q3 2023 Nov 14, 2023	SELL	$13.71 - $19.64 $43,460 - $62,258	-3,170 Reduced 12.08%	23,061 $316,000
Q2 2023 Aug 11, 2023	BUY	$6.11 - $17.83 $58,588 - $170,971	9,589 Added 57.62%	26,231 $421,000
Q1 2023 May 18, 2023	BUY	$5.41 - $18.3 $89,952 - $304,274	16,627 Added 110846.67%	16,642 $129,000
Q1 2023 May 11, 2023	SELL	$5.41 - $18.3 $616,561 - $2.09 Million	-113,967 Reduced 99.99%	15 $0
Q4 2022 Feb 13, 2023	BUY	$15.74 - $22.19 $608,382 - $857,687	38,652 Added 51.31%	113,982 $2.21 Million
Q3 2022 Nov 14, 2022	SELL	$13.27 - $22.31 $313,251 - $526,649	-23,606 Reduced 23.86%	75,330 $1.61 Million
Q2 2022 Aug 11, 2022	SELL	$12.82 - $23.4 $649,525 - $1.19 Million	-50,665 Reduced 33.87%	98,936 $1.35 Million
Q1 2022 May 11, 2022	BUY	$17.8 - $28.06 $1.31 Million - $2.06 Million	73,475 Added 96.52%	149,601 $3.51 Million
Q4 2021 Feb 10, 2022	SELL	$15.01 - $35.8 $37,915 - $90,430	-2,526 Reduced 3.21%	76,126 $2.04 Million
Q3 2021 Nov 12, 2021	BUY	$13.71 - $30.6 $1.08 Million - $2.41 Million	78,652 New	78,652 $1.37 Million

Others Institutions Holding VERA

# of Institutions

193

Shares Held

63.9M

Call Options Held

68.1K

Put Options Held

88.6K

View Full List

About Vera Therapeutics, Inc.

Ticker VERA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 27,042,300
Market Cap $773M
Description
Vera Therapeutics, Inc., a clinical stage biotechnology company, focuses on developing and commercializing treatments for patients with serious immunological diseases in the United States. Its lead product candidate is atacicept, a fusion protein self-administered as a subcutaneous injection that is in Phase IIb clinical trial for patients with ...

More about VERA

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Jpmorgan Chase & CO, based on Form 13F filings with the SEC.

News

Stay updated on Jpmorgan Chase & CO with notifications on news.

Account

Jpmorgan Chase & CO Vera Therapeutics, Inc. Transaction History